NIH-funded research R01 grant

Gut microbiome metabolite 3-PPA helps beige fat and energy balance

Official title: Gut Microbiota-Derived 3-PPA as a Metabolic Modulator of Beige Adipogenesis and Energy Homeostasis

Funded at University of Illinois at Chicago · NIH-11341044 · Data updated 2026-11-12

A study will look at how a gut-friendly chemical called 3-PPA may boost beige fat to burn calories and improve blood sugar in adults with type 2 diabetes risk.

More Microbiota research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Chicago
NIH-funded
Lab location1 site (Chicago, UNITED STATES)
Project startJune 1, 2026
Project endApril 30, 2031
Funding year2026
Award (this year)$786,728
NIH project number1R01DK146958-01
Project IDNIH-11341044 on NIH RePORTER

Who could benefit from this research

Could help

Adults with obesity-related metabolic risks or adult-onset diabetes who are able to participate in metabolic studies and have no contraindications to study procedures.

Less likely to help

Individuals without metabolic dysfunction or those unable to participate in metabolic or immune studies may derive no direct benefit.

What this research studies

This project explores whether a gut microbiome metabolite, 3-PPA, can trigger beige fat cells to grow and help regulate energy use and insulin in people with obesity-related diabetes risks. Researchers will examine immune signals in fat tissue, focusing on how GPR40 in macrophages and CXCL13-Tfh cell interactions contribute to this process. The team plans experiments in cellular and animal models to map the pathways and then translate promising findings toward potential therapies for metabolic disease. If successful, the work could point to new approaches that harness the gut–immune–fat connection to improve glucose control.

Why it matters

Potential benefit: If successful, the research could lead to new ways to boost energy burning and glucose control through the gut–immune–fat axis.

How similar studies have gone: Previous work suggests gut metabolites can influence fat and metabolism, but this specific 3-PPA–immune–adipose pathway is being explored

Where this research is happening

  • University of Illinois at Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Jiang, Yuwei — University of Illinois at Chicago
  • Study coordinator: Jiang, Yuwei

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.